1.

Introduction of treatment with low-dose gemcitabine in long infusion is a new treatment for systemic treatment of lung cancer

Gemcitabine in low dose in long infusion is a new treatment. Our group was among the first worldwide to introduce this treatment for lung cancer, and especially for patients with squamous carcinoma. Of importance are economic aspects: with only 20% of the normal dose, at least comparable clinical effect has been achieved. The treatment is effective and safe

F.21 Development of new health/diagnostic methods/procedures

COBISS.SI-ID: 23668185

2.

Low-dose gem in long infusion and cisplatin for mesothelioma.

New treatment for mesothelioma. The treatment appears superior to any of the currently approved treatments for this disease

F.21 Development of new health/diagnostic methods/procedures

COBISS.SI-ID: 643963